Rondo-Pak is partnering with Catalent, to provide packaging materials for critical medicines, including COVID-19. The FDA has recently granted emergency use authorization to Johnson & Johnson for their COVID-19 vaccine, of which, Catalent has partnered to provide large-scale vial filling and packaging on the new dedicated high-speed lines at their biologics facility in Bloomington, IN.
“We have been working directly with many of the top global pharmaceutical companies to provide packaging for their COVID-19 vaccines, adjuvants and medications, as well as test kits and product information materials,” said Bob Reilley, President and COO, Rondo-Pak.
